4D Molecular Therapeutics, Inc. (FDMT)

4D Molecular Therapeutics Statistics

Total Valuation

FDMT has a market cap or net worth of $150.48 million. The enterprise value is -$325.76 million.

Market Cap	150.48M
Enterprise Value	-325.76M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025, after market close.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

FDMT has 46.30 million shares outstanding. The number of shares has increased by 37.86% in one year.

Current Share Class	46.30M
Shares Outstanding	46.30M
Shares Change (YoY)	+37.86%
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	3.90%
Owned by Institutions (%)	80.18%
Float	34.31M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4,191.62
Forward PS	92.78
PB Ratio	0.33
P/TBV Ratio	0.30
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.92, with a Debt / Equity ratio of 0.05.

Current Ratio	14.92
Quick Ratio	14.58
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -39.31% and return on invested capital (ROIC) is -27.38%.

Return on Equity (ROE)	-39.31%
Return on Assets (ROA)	-26.08%
Return on Invested Capital (ROIC)	-27.38%
Return on Capital Employed (ROCE)	-35.36%
Revenue Per Employee	$163
Profits Per Employee	-$708,670
Employee Count	227
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -89.58% in the last 52 weeks. The beta is 2.82, so FDMT's price volatility has been higher than the market average.

Beta (5Y)	2.82
52-Week Price Change	-89.58%
50-Day Moving Average	4.55
200-Day Moving Average	10.60
Relative Strength Index (RSI)	30.71
Average Volume (20 Days)	677,861

Short Selling Information

The latest short interest is 5.03 million, so 10.86% of the outstanding shares have been sold short.

Short Interest	5.03M
Short Previous Month	5.24M
Short % of Shares Out	10.86%
Short % of Float	14.66%
Short Ratio (days to cover)	7.40

Income Statement

In the last 12 months, FDMT had revenue of $37,000 and -$160.87 million in losses. Loss per share was -$2.98.

Revenue	37,000
Gross Profit	-141.26M
Operating Income	-187.84M
Pretax Income	-109.89M
Net Income	-160.87M
EBITDA	-183.19M
EBIT	-187.84M
Loss Per Share	-$2.98

Balance Sheet

The company has $424.88 million in cash and $24.61 million in debt, giving a net cash position of $480.85 million or $10.39 per share.

Cash & Cash Equivalents	424.88M
Total Debt	24.61M
Net Cash	480.85M
Net Cash Per Share	$10.39
Equity (Book Value)	510.61M
Book Value Per Share	11.15
Working Capital	405.78M

Cash Flow

In the last 12 months, operating cash flow was -$134.59 million and capital expenditures -$3.79 million, giving a free cash flow of -$138.37 million.

Operating Cash Flow	-134.59M
Capital Expenditures	-3.79M
Free Cash Flow	-138.37M
FCF Per Share	-$2.99

Margins

Gross Margin	n/a
Operating Margin	-507,678.38%
Pretax Margin	-434,778.38%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FDMT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.86%
Shareholder Yield	n/a
Earnings Yield	-103.73%
FCF Yield	-89.22%

Analyst Forecast

The average price target for FDMT is $35.00, which is 976.92% higher than the current price. The consensus rating is "Buy".

Price Target	$35.00
Price Target Difference	976.92%
Analyst Consensus	Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	394.04%
EPS Growth Forecast (5Y)	5.97%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FDMT has an Altman Z-Score of 9.55 and a Piotroski F-Score of 1.

Altman Z-Score	9.55
Piotroski F-Score	1